Lab Notes: Tela Bio secures $50M loan deal; Senzo's home Covid-19 test achieves 100% accuracy
June 03, 2022 at 13:21 PM EDT
Trevose-based Lannett Co. provided an update on its ongoing pivotal clinical trial of biosimilar insulin glargine.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|